Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

Abstract Background Cardiovascular diseases and especially Acute Coronary Syndrome (ACS) constitute a major health issue impacting millions of patients worldwide. Being a leading cause of death and hospital admissions in many European countries including Spain, it accounts for enormous amounts of he...

Full description

Bibliographic Details
Main Authors: Margarita-Ioanna Koufaki, Vasileios Fragoulakis, Xando Díaz-Villamarín, Kariofyllis Karamperis, Athanassios Vozikis, Jesse J. Swen, Cristina L. Dávila-Fajardo, Konstantinos Z. Vasileiou, George P. Patrinos, Christina Mitropoulou
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Human Genomics
Subjects:
Clopidogrel
Economic evaluation
Cost-effectiveness
Pharmacogenomics-guided treatment
Spain
Acute coronary syndrome
Online Access:https://doi.org/10.1186/s40246-023-00495-3

Internet

https://doi.org/10.1186/s40246-023-00495-3

Similar Items